Meant logo

Meant Review

7.3
★★★★☆3.7/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10

Best for: compounded semaglutide or tirzepatide with free care coaching and a price that holds as your dose rises

Meant scores highest on the strength of its clinical program: drug options and dosing support.

Semaglutide

$179/mo · “starting at” price

Tirzepatide

$269/mo · “starting at” price
Same price at every dose

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Included

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Meant is a telehealth weight-loss program that offers compounded semaglutide (injection or oral), compounded tirzepatide, lower-dose microdose plans and brand Ozempic and Zepbound, with care through OpenLoop Health clinicians. Every plan includes free 1:1 care coaching and shipping, and prepay plans add a supplement kit. Compounded semaglutide starts at $179 a month, tirzepatide at $269 and microdose plans at $169.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideOral OptionMicrodose OptionsZepboundLegitScript VerifiedSame Price Every Dose

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to Meant

7.7/ 10
Verified partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Verified partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Verified partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Meant logo
3.7 / 5
Our editorial rating
Visit Meant →

from $179/mo (“starting at” price) · no insurance needed

Meant at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide, Zepbound
Starting price
$179/mo (“starting at” price)
Pricing model
Flat: dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping · Coaching
FDA status
No FDA warning letter on record

How we scored Meant

Each dimension is scored algorithmically from Meant’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

7.6/10

At $179/mo (“starting at” price), Meant runs in line with the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

8.2/10

Meant offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

7.1/10

Online intake and platform experience (consult included in the price); 8 platform features disclosed.

Trust & Safety15%

7.0/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

5.8/10

Meant's exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

6.9/10

Coaching/dietitian access included.

6scored dimensions
669providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Meant review

Last checked November 2026
  • Confirmed current pricing across 7 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$169–$1,399/mo across 7 dose/plan tiers (checked November 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Meant

We walked Meant’s public signup flow in November 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1'Get Started' on the site opens a short quiz that asks your weight-loss goal and what has held you back
  2. 2The quiz then asks for your email to continue to the full health assessment
  3. 3Product buttons go straight to the intake run by OpenLoop Health, which opens on a 'Security Check' robot test
  4. 4Meant says a clinician reviews the assessment, usually within one business day, and you are charged only if treatment is approved
Price shown before you start
  • Each product page shows a 'from' monthly price before you start, but not the plan lengths or what each plan charges up front
  • The FAQ says the supplement kit grows with plan length (3, 6 or 12 months) and that monthly plans don't include it
  • Meant says your price stays the same for the plan even if your dose goes up
  • The homepage money-back promise covers canceling before your medication ships; the refund policy page doesn't include that
  • Cancellation is by email or in your account, at least 72 hours before the billing date

Meant customer support

Hours
Contact form replies within one business day; the site advertises 24/7 member support

GLP-1 medications Meant offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Advertised from price (plan lengths shown after the intake)Compounded
$179/mo
semaglutide

Weekly injection 'from $179/mo'; Meant says your price stays the same when your dose goes up during the plan.

Oral semaglutide, advertised from price (plan lengths shown after the intake)Compounded
$209/mo
semaglutide

Daily tablet 'from $209/mo'.

Advertised from price (plan lengths shown after the intake)Compounded
$269/mo
tirzepatide

Weekly injection 'from $269/mo'; Meant says your price stays the same when your dose goes up during the plan.

Microdose plan, starting price (plan lengths shown after the intake)Compounded
$169/mo
semaglutide

Lower, clinician-set dose 'from $169/mo'.

Microdose plan, starting price (plan lengths shown after the intake)Compounded
$169/mo
tirzepatide

Lower, clinician-set dose 'from $169/mo'.

Ozempic, cash price shown on the siteBrand-name
$1,299/mo
semaglutide

Listed at $1299/mo; Meant says you can use insurance or pay directly and will see your exact cost before you are charged.

Zepbound, cash price shown on the siteBrand-name
$1,399/mo
tirzepatide

Listed at $1399/mo; Meant says you can use insurance or pay directly and will see your exact cost before you are charged.

Ready to get started?

Plans and promotions change often, so check Meant's current pricing and active discounts before you decide.

See Meant pricing →

What we like

  • Shows a LegitScript seal served by LegitScript itself
  • Names its four partner pharmacies, with addresses, in its terms
  • Your plan price stays the same when your dose goes up
  • Free 1:1 care coaching every two weeks, plus free shipping
  • No charge until a clinician approves treatment, and a full refund if you're found ineligible
  • Support by phone, email and a contact form
  • Brand Ozempic and Zepbound are also offered, with insurance or cash pay

Watch-outs

  • Prices are 'from' figures; plan lengths and up-front totals appear only after the intake
  • The homepage promises a full refund if you cancel before your medication ships, but the written refund policy gives none on cancellation
  • The supplement kit comes only with prepay plans, not monthly plans
  • You must cancel at least 72 hours before your billing date or you're charged for another cycle
  • Its terms and refund policy list their effective date as 'Pending'
  • The semaglutide microdose page calls it a dual-action GLP-1 and GIP injection, which describes tirzepatide
  • Brand Ozempic at $1,299 and Zepbound at $1,399 a month are high cash prices
  • Disputes go to binding arbitration, with a class action waiver

Is Meant worth it?

Meant built its program around one core idea: compounded semaglutide or tirzepatide with free care coaching and a price that holds as your dose rises. It runs $179/month (“starting at” price) at every dose; there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. Its standout is a needle-free oral option for people who would rather not inject.

It offers a microdosing option. It also is LegitScript-certified and charges the same price at every dose.

How much Meant costs

Compounded semaglutide runs $179–$209/month depending on plan, the low end a “starting at” price, compounded tirzepatide runs $269/month (“starting at” price), brand-name semaglutide runs $1,299/month (entry-tier price), and brand-name tirzepatide runs $1,399/month (entry-tier price).

Because Meant's headline figure is a “starting at” price, we don't set it against the roughly $185 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Meant with the month-to-month prices of the alternatives below instead.

MadeMed (about $179/month) is one of the closest alternatives to weigh Meant against.

Medications: what Meant prescribes

Meant prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. Pick the brand-name pen for the FDA-approved product, or the compounded version to cut the monthly cost, with the trade-off that a compounded drug isn't FDA-approved as a finished formulation.

Meant's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.

Who Meant is best for, and who should skip it

A good fit if you…

  • are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
  • want coaching and follow-up built into the price already, instead of sold separately as an upsell.

Look elsewhere if you…

  • need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.

Bottom line

Meant is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.

The Bottom Line

Meant scores highest on the strength of its clinical program: drug options and dosing support.

Score: 7.3/10Best for: compounded semaglutide or tirzepatide with free care coaching and a price that holds as your dose risesFrom: $179/mo (“starting at” price)

Ready to start with Meant?

From $179/mo (“starting at” price). See current pricing and start your free consultation.

Head-to-head

Compare Meant vs…

Meant scores7.3/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Meant is a telehealth weight-loss program that offers compounded semaglutide (injection or oral), compounded tirzepatide, lower-dose microdose plans and brand Ozempic and Zepbound, with care through OpenLoop Health clinicians. Every plan includes free 1:1 care coaching and shipping, and prepay plans add a supplement kit. Compounded semaglutide starts at $179 a month, tirzepatide at $269 and microdose plans at $169. We scored it 7.3/10 across our six-dimension editorial framework.
Yes. Meant is a legitimate telehealth provider. Our editors independently verified its pricing and offering and scored it 7.3/10 across our six-dimension framework. As with any medication, consult a licensed clinician before starting.
Meant starts at $179/month (“starting at” price). The price is flat across doses, so it doesn't increase as you titrate up. See the pricing table above for every tier.
Meant doesn't use public promo or coupon codes. Third-party sites advertising "Meant discount codes" are typically fake; any current offer applies automatically through the link on this page.
Meant hasn't published its exact state footprint. Confirm coverage in your state before signing up.
Meant offers semaglutide (the active drug in Wegovy/Ozempic) and tirzepatide (the active drug in Zepbound/Mounjaro). You can choose FDA-approved brand-name or lower-cost compounded versions. A needle-free oral option is also available.
Meant offers both. Compounded semaglutide/tirzepatide from a licensed pharmacy is the lower-cost path; FDA-approved brand-name pens cost more but are the reference products. We explain the trade-offs in the review above.
Meant is a cash-pay program. No insurance is required, which is why the monthly price is transparent up front.
Meant's price includes medication, the clinician consult, shipping and coaching. See the "what's included" strip near the top of this review.
You complete an online intake, a licensed clinician looks at whether a GLP-1 fits your situation, and, if you're approved, your medication ships to your door. You can begin the consultation directly on Meant's site.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: Prices are 'from' figures; plan lengths and up-front totals appear only after the intake; The homepage promises a full refund if you cancel before your medication ships, but the written refund policy gives none on cancellation; The supplement kit comes only with prepay plans, not monthly plans; You must cancel at least 72 hours before your billing date or you're charged for another cycle. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Meant review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Meant's current pricing

Plans from $179/mo (“starting at” price). Start your free consultation to check eligibility and today's price.